| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9023391 | DEXCEL PHARMA | Stable benzimidazole formulation |
Aug, 2025
(1 year, 3 months from now) | |
Omeprazole is owned by Dexcel Pharma.
Omeprazole contains Omeprazole.
Omeprazole has a total of 1 drug patent out of which 0 drug patents have expired.
Omeprazole was authorised for market use on 04 December, 2007.
Omeprazole is available in tablet, delayed release;oral dosage forms.
The generics of Omeprazole are possible to be released after 16 August, 2025.
Drugs and Companies using
OMEPRAZOLE ingredient
Market Authorisation Date:
04 December, 2007Treatment:
NADosage:
More Information on Dosage
OMEPRAZOLE family patents
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10835488 | DEXCEL | Stable orally disintegrating pharmaceutical compositions |
Dec, 2036
(12 years from now) | |
| US10076494 | DEXCEL | Stable orally disintegrating pharmaceutical compositions |
Dec, 2036
(12 years from now) | |
Omeprazole is owned by Dexcel.
Omeprazole contains Omeprazole.
Omeprazole has a total of 2 drug patents out of which 0 drug patents have expired.
Omeprazole was authorised for market use on 05 July, 2017.
Omeprazole is available in tablet, orally disintegrating, delayed release;oral dosage forms.
The generics of Omeprazole are possible to be released after 08 December, 2036.
Drugs and Companies using
OMEPRAZOLE ingredient
Market Authorisation Date:
05 July, 2017Treatment:
NADosage:
More Information on Dosage
OMEPRAZOLE family patents